Furthermore, we discovered PCDH20 impeded AKT/β-catenin signaling via stabilizing DC mediated by MAP3K9 downregulation, which may pave the way for identifying potential molecular target based on a deeper understanding of the regulatory mechanism in ESCC. Here, MAP3K9 is linked to esophageal squamous cell carcinoma.